4C085 生体内診断剤技術 Patent Trends
The Theme Code "生体内診断剤技術" had 858 patent application filings in the publication-lag-adjusted comparison period (2024-01-01 to 2024-10-31). This is a significantly decreased of -1,041 filings (-54.8%) over 1,899 they had in the same period of the previous year (2023-01-01 to 2023-10-31).
The highest number of filings in 2021 with 3,277 cases, and their lowest number in 2024 with 880 cases (years covered: 2021, 2022, 2023, 2024).
The mean of the number of filings over the last 4 years (2021 to 2024, 9,249 cases in total) is 2,312, and the median is 2,546. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
| Index | Value |
|---|---|
| Average | 2,312 patents |
| Std Dev | 891 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 48 cases | -94.5% |
| 2024 year | 880 cases | -62.4% |
| 2023 year | 2,338 cases | -15.11% |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 生体内診断剤技術[4C085] for the period of the last 6 years (2020 to 2025). You can compare the information in this report with the trends in your competitors’ patent filings and technologies.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 生体内診断剤技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, and their top coapplicants (joint research partners, alliance partners). It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
- Table of Contents
- Foreign Patent Analysis Report
- Patent Filing Summary for 生体内診断剤技術
- Search Set (Search Formula/Analysis Patents)
- Recent publications
- Related Patent Analysis Report
- Competitors Information
- Top company Information
- Provision of patent information to the media
- About this Site
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
生体内診断剤技術, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 生体内診断剤技術 over the last 6 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
Filing trend data
| Year | Cases |
|---|---|
| 2021 | 3,277 |
| 2022 | 2,754 |
| 2023 | 2,338 |
| 2024 | 880 |
| 2025 | 48 |
Patent Landscape ({{ld.d.db_name | country_map: 'en'}})
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for 生体内診断剤技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
In addition, by visually representing the patent data in this manner, you can convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
Characteristic Terms (Importance)
The following is a list of words (characteristic terms) often used in 生体内診断剤技術 patent applications. Characteristic terms with a higher importance are used in more patents/patent applications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 9,297 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
生体内診断剤技術[4C085]
Recent publications
| Publication No. | Title | Bibliographic info | Theme |
|---|---|---|---|
| 1. JPA2026-142820 | 磁性ビーズ | ・Applicant デンカ株式会社 ・Filing date 2025-02-27 ・Publication date 2026-09-08 | 4C085, 4J002 |
| 2. JPA2026-143281 | 腫瘍細胞のＰＤ－Ｌ１の発現抑制剤、がんを治療するための併用薬および抗がん剤 | ・Applicant 学校法人藤田学園 ・Filing date 2025-02-27 ・Publication date 2026-09-08 | 4C084, 4C085, 4C086 |
| 3. JPP7917612 | 樹状細胞腫瘍ワクチン及びその使用 | ・Applicant シェンチェン・フロンティアゲート・バイオテクノロジー・カンパニー・リミテッド ・Filing date 2023-01-09 ・Publication date 2026-09-08 | 4B064, 4B065, 4C076, 4C084, 4C085, +1 more |
| 4. JPP7917443 | 再生性ポリペプチドおよびその使用 | ・Applicant ジュベナ・セラピューティクス・インコーポレイテッド ・Filing date 2020-12-22 ・Publication date 2026-09-08 | 4C076, 4C084, 4C085, 4C086, 4C206, +1 more |
| 5. JPP7917452 | 抗ＣＤ９３構築物およびその使用 | ・Applicant ダイナミキュアバイオテクノロジーエルエルシー ・Filing date 2021-06-02 ・Publication date 2026-09-08 | 4B065, 4C084, 4C085, 4C087, 4H045 |
| 6. JPP7917529 | ヒト化補体５Ａ受容体１抗体及びその使用方法 | ・Applicant ビステラインコーポレイテッド ・Filing date 2022-01-13 ・Publication date 2026-09-08 | 4B064, 4B065, 4C085, 4H045 |
| 7. JPP7915985 | 薬剤 | ・Applicant ザリージェンツオブザユニバーシティオブミシガン ・Filing date 2020-09-23 ・Publication date 2026-09-07 | 4B001, 4B014, 4B018, 4B041, 4B065, +4 more |
| 8. JPP7916289 | 抗ｈＫ２キメラ抗原受容体（ＣＡＲ） | ・Applicant ヤンセンバイオテツクインコーポレーテツド ・Filing date 2020-07-23 ・Publication date 2026-09-07 | 4B063, 4B065, 4C085, 4C087, 4H045 |
| 9. JPP7916327 | 細胞培養法 | ・Applicant アムジェンインコーポレイテッド ・Filing date 2021-12-21 ・Publication date 2026-09-07 | 4B064, 4C076, 4C084, 4C085, 4H045 |
| 10. JPP7916355 | ＳＡＲＳ－ＣｏＶ－２に対するヒト中和モノクローナル抗体、及びそれらの使用 | ・Applicant アンスティチュパスツール ・Filing date 2022-04-01 ・Publication date 2026-09-07 | 4B064, 4B065, 4C076, 4C084, 4C085, +3 more |
| 11. JPP7916396 | 改良されたコロナウイルスワクチン | ・Applicant アカデミアシニカ ・Filing date 2022-04-12 ・Publication date 2026-09-07 | 4B065, 4C085, 4H045 |
| 12. JPP7916397 | Ｈ２Ｌ２とＨＣＡｂ構造を有する結合タンパク質 | ・Applicant ハーバー・バイオメド・(シャンハイ)・カンパニー・リミテッド ・Filing date 2021-06-29 ・Publication date 2026-09-07 | 4B065, 4C076, 4C085, 4H045 |
| 13. JPP7916316 | 抗ＦｃＲＨ５／抗ＣＤ３二重特異性抗体による処置のための投与 | ・Applicant ジェネンテックインコーポレイテッド ・Filing date 2021-10-05 ・Publication date 2026-09-07 | 4C084, 4C085, 4H045 |
| 14. JPP7916319 | 網膜の血栓性疾患の処置のための抗セマフォリン３Ａ抗体及びその使用 | ・Applicant ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング ・Filing date 2021-10-22 ・Publication date 2026-09-07 | 4B064, 4C085, 4H045 |
| 15. JPP7916033 | 抗－ＣＤ３００ｃ抗体を利用した併用療法 | ・Applicant セントリックスバイオインコーポレイテッド ・Filing date 2022-05-13 ・Publication date 2026-09-07 | 4C084, 4C085, 4C086, 4H045 |
Same industry / competition company information (JP)
{'ja': '技術テーマ「生体内診断剤技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme 生体内診断剤技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 73 cases, followed by ジェネンテックインコーポレイテッド with 37 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 73 cases |
| ジェネンテックインコーポレイテッド | 37 cases |
| イーライリリーアンドカンパニー | 37 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 33 cases |
| ヤンセンバイオテツクインコーポレーテツド | 19 cases |
| ノバルティスアーゲー | 15 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 248 cases, followed by ジェネンテックインコーポレイテッド with 186 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 248 cases |
| ジェネンテックインコーポレイテッド | 186 cases |
| ヤンセンバイオテツクインコーポレーテツド | 164 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 142 cases |
| ノバルティスアーゲー | 116 cases |
| イーライリリーアンドカンパニー | 101 cases |
Same industry / competition company JP patent filing ranking
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 6 companies in the same industry over the past 6 years.
Ranking data
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 248 |
| ジェネンテックインコーポレイテッド | 186 |
| ヤンセンバイオテツクインコーポレーテツド | 164 |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 142 |
| ノバルティスアーゲー | 116 |
| イーライリリーアンドカンパニー | 101 |
Top company information (JP)
{'ja': '技術テーマ「生体内診断剤技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme 生体内診断剤技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 73 cases, followed by ジェネンテックインコーポレイテッド with 37 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 73 cases |
| ジェネンテックインコーポレイテッド | 37 cases |
| イーライリリーアンドカンパニー | 37 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 248 cases, followed by ジェネンテックインコーポレイテッド with 186 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 248 cases |
| ジェネンテックインコーポレイテッド | 186 cases |
| イーライリリーアンドカンパニー | 101 cases |
Top company JP patent filing ranking
Below is a ranking of the number of JP patent applications by 生体内診断剤技術’s top 3 coapplicants over the last 6 years.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
Ranking data
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 248 |
| ジェネンテックインコーポレイテッド | 186 |
| ヤンセンバイオテツクインコーポレーテツド | 164 |
Top company, Change in the Number of JP Patents
Below is a patent map showing the changes in the numbers of JP patent filings by 生体内診断剤技術’s top 3 coapplicants over the last 6 years.
Ranking data
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 248 |
| ジェネンテックインコーポレイテッド | 186 |
| ヤンセンバイオテツクインコーポレーテツド | 164 |
Top company details
Trends in filing of joint patent applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド
生体内診断剤技術 filed 248 joint applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 248 cases in total) is 49.6, and the median is 45.0. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
Because some years show zero filings in the collected data, strong trend claims are avoided; see the yearly table. The highest number of filings in 2020 with 89 cases, and their lowest number in 2024 with 22 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 49.6 patents |
| Std Dev | 22.0 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 0 cases | -100% |
| 2024 year | 22 cases | -56.9% |
| 2023 year | 51 cases | +24.39% |
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
生体内診断剤技術 filed 186 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 185 cases in total) is 37.0, and the median is 38.0. The coefficient of variation (standard deviation/mean) is 0.5, and filings have been large fluctuations.
The highest number of filings in 2021 with 60 cases, and their lowest number in 2024 with 10 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 37.0 patents |
| Std Dev | 17.8 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 1 cases | -90.0% |
| 2024 year | 10 cases | -61.5% |
| 2023 year | 26 cases | -31.6% |
Trends in filing of joint patent applications with イーライリリーアンドカンパニー
生体内診断剤技術 filed 101 joint applications with イーライリリーアンドカンパニー for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 96 cases in total) is 19.2, and the median is 17.0. The coefficient of variation (standard deviation/mean) is 0.3, and filings have been large fluctuations.
The highest number of filings in 2022 with 31 cases, and their lowest number in 2024 with 11 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 19.2 patents |
| Std Dev | 6.7 |
| COV | 0.3 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 5 cases | -54.5% |
| 2024 year | 11 cases | -47.6% |
| 2023 year | 21 cases | -32.3% |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント